- genetics
- diabetes
- phenotyping
- +۵ مورد دیگر
Martin Hrabě de Angelis is a Research Director at Helmholtz Munich and Full Professor and Chair of Experimental Genetics at Technical University Munich. He serves as Director of the Institute of Experimental Genetics at Helmholtz Munich and chairs the European research consortium INFRAFRONTIER ERIC. Positions: Research Director (since 2020), Full Professor (since 2003), Director of Institute of Experimental Genetics (since 2000) Key Affiliations: German Center for Diabetes Research (DZD), International Mouse Phenotyping Consortium (IMPC), INFRAFRONTIER Ltd. His research focuses on genetics, diabetes, phenotyping, epigenetics, and large-scale functional genomics , with notable work on ENU-mutagenesis screens and epigenetic inheritance of metabolic diseases. Recent publications highlight his contributions to understanding: Genetic underpinnings of cancer cachexia and ocular diseases Novel gene therapies for rare metabolic disorders Sex-based differences in exercise physiology Chemoproteomic approaches to drug discovery He has received prestigious honors including the Paul Langerhans Medal (2021), IMPC Award of Excellence (2019), and multiple honorary doctorates (2018-2017). As co-founder of the German Center for Diabetes Research and leader of international consortia, he bridges translational research and infrastructure development. His work involves: Establishing the German Mouse Clinic for systemic disease modeling Identifying 51 novel genes linked to metabolic diseases Advancing MALDI mass spectrometry imaging techniques Investigating progeria treatments and neurodevelopmental syndromes





